Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System. [PDF]
Sridharan K, Sivaramakrishnan G.
europepmc +1 more source
APIXABAN REDUCES HOSPITALIZATIONS IN PATIENTS WITH VTE: AN ANALYSIS OF THE AMPLIFY TRIAL
Xianchen Liu +5 more
openalex +1 more source
Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia. [PDF]
Rodriguez V +9 more
europepmc +1 more source
Heavy menstrual bleeding on Rivaroxaban - Comparison with Apixaban [PDF]
Bethan Myers, Amy Webster
openalex +1 more source
Silent threat after surgery: subclavian and axillary vein thrombosis following clavicle fixation leading to thoracic outlet syndrome. [PDF]
Gholipour M +4 more
europepmc +1 more source
Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients [PDF]
Thomas Vanhove +6 more
openalex +1 more source
PCV72 Economic Evaluation of Ivabradine in Chronic Heart Failure in Greece [PDF]
Kourlaba, G. +5 more
core +1 more source
Three Year Follow-Up of Reduced Dose of Direct Oral Anticoagulants for Extended Treatment of Venous Thromboembolism: An Ambispective Cohort Study. [PDF]
Valeriani E +9 more
europepmc +1 more source
Concerns Regarding the Use of Oral Anticoagulants (Rivaroxaban and Apixaban) for Venous Thromboembolism Prophylaxis in Plastic Surgery Patients [PDF]
Eric Swanson
openalex +1 more source

